News & Insights

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced that on September 25, 2023, the Compensation Committee of Sonendo’s Board of Directors granted restricted stock unit awards covering an aggregate of 14,000 shares of its common stock to two new, non-executive employees to induce them to join the company. The awards were granted under Sonendo’s 2023 Employment Inducement Incentive Award P

OXFORD, England & IRVINE, Calif. & PASADENA, Calif.--(BUSINESS WIRE)--Rockley continues to make rapid progress towards noninvasive glucose sensing using its proprietary silicon photonics platform.

LOS ANGELES--(BUSINESS WIRE)--The FDA has granted Orphan Drug Designation to Puma Biotechnology's drug candidate alisertib for the treatment of small cell lung cancer.

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Restore Hyper Wellness, a leader in proactive health and wellness services with more than 225 studios in 40 states, announced that Wave Neuro, a leader in personalized Braincare™, has been selected as the winner of Restore’s 2023 Technology Award. “Wave Neuro is honored to be chosen as the recipient of the 2023 Restore Technology Award by their outstanding national operator network,” said Fred Walke, Chief Executive Officer of Wave Neuro. “Restore's astou

ALISO VIEJO, Calif.--(BUSINESS WIRE)-- #microvention--MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, today announced that the SOFIA™ EX 5F 115 cm Intracranial Support Catheter (Soft TOrqueable catheter For Intracranial Access) has received FDA 510(k) clearance on September 15, 2023, for transradial access in addition to transfemoral access. The unique design of the SOFIA™ EX 5F Catheter allows for great trackability and a large inside lumen provides a fast

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus was awarded a new funded grant from the U.S. FDA to validate best practices for PBBM/PBPK modeling workflows to simulate VBE studies.

RIVERSIDE, Calif.--(BUSINESS WIRE)-- #flopatch--Riverside University Health System adopts FloPatch by Flosonics, elevating sepsis care with precision fluid management during Sepsis Awareness Month.

LOS ANGELES--(BUSINESS WIRE)--Aspect Imaging, LLC, the global leader in disruptive MRI systems for clinically complex neonatal patients announced its Embrace® Point of Care Neonatal MRI System has received an Innovative Technology contract from Vizient, Inc. the nation’s largest provider-driven healthcare performance improvement company. The contract was awarded based on the recommendation of the Embrace® by hospital experts who serve on one of Vizient’s provider customer-led councils, and it s

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced that management will participate in the upcoming LD Micro Main Event XVI Conference. Management is scheduled to present on Wednesday, October 4th at 2:30 p.m. Pacific Time/ 5:30 p.m. Eastern Time. A webcast of the presentation will be available on the “Investors” section of the company’s website at: investor.sonendo.com. About Sonendo So

PASADENA, Calif.--(BUSINESS WIRE)--Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced the appointment of Barbara J. Klencke, M.D., to its board of directors. Dr. Klencke has more than 20 years of biopharmaceutical product development experience, and she most recently served as chief medical officer and chief development officer at Sierra Oncology through mid-20

THOUSAND OAKS, Calif.--(BUSINESS WIRE)---- $ATRA #CART--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today reported important progress related to the regulatory pathway for tabelecleucel (tab-cel®) in the U.S. Following productive discussions between Atara and the U.S. Food and Drug Administration (FDA), the FDA and Atara

LONG BEACH, Calif.--(BUSINESS WIRE)-- #businessgrowth--California Manufacturing Technology Consulting® (CMTC) recently delivered Quality and Lean services to medical instrument manufacturer MRIaudio to help the company boost their sales. Established in 2012, MRIaudio is a family-owned business that develops and manufactures MRI compatible audio systems for medical imaging facilities. This technology masks the noise of MRI machines, helping MRI patients to feel more comfortable during their scans. In addition, th

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced that management will participate in the upcoming Gilmartin Group Emerging Growth Company Showcase. Management is scheduled to present on Thursday, September 21st at 9:00 a.m. Pacific Time/ 12:00 p.m. Eastern Time. A webcast of the presentation will be available on the “Investors” section of the company’s website at: investor.sonendo.com.

SANTA MONICA, Calif.--(BUSINESS WIRE)--Kite, a Gilead Company (Nasdaq: GILD), today announced results from the Phase 2 ALYCANTE study, led and sponsored by the French collaborative group LYSA/LYSARC, for use of its chimeric antigen receptor (CAR) T-cell therapy Yescarta® (axicabtagene ciloleucel) in patients with relapsed/refractory (R/R) large B-cell lymphoma (LBCL) after one prior line of therapy who were deemed ineligible for high-dose chemotherapy (HDCT) and autologous stem cell transplanta

LOS ANGELES--(BUSINESS WIRE)-- #childrenshealth--A nationally renowned medical leader, clinician and researcher in cancer and blood diseases, Alan S. Wayne, MD, has been appointed as the Senior Vice President of Academic Affairs and Pediatrician-in-Chief at Children’s Hospital Los Angeles (CHLA), and Chair of the Department of Pediatrics at the Keck School of Medicine of the University of Southern California (USC). Dr. Wayne will lead the implementation of the Department’s strategic and operating plans; recruitme

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, will host Vision 2026, the Company’s investor day, at the Nasdaq MarketSite in Times Square today. To honor the occasion and celebrate the 40th anniversary of being listed as a public company, Tom Frinzi, Chair of the Board and CEO, along with the company’s executive leadership team and STAAR employees, have been invited to ring the Nasda

COSTA MESA, Calif.--(BUSINESS WIRE)--Pyramid, a leading large molecule drug product contract development and manufacturing organization (“CDMO”), announced the appointment of Amy Driver as Vice President of Business Development and Peter Buzy to the Board of Directors. “We are excited to have Amy and Pete join the Pyramid leadership team and the Pyramid Board, respectively, as we continue to invest in our team and resources to support our next phase of growth,” commented Medhat Gorgy, Chief Exe

PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced data on its pipeline of pulmonary targeted RNA interference (RNAi) therapeutic candidates, including clinical results for ARO-RAGE, being presented at the European Respiratory Society (ERS) International Congress 2023 in Milan, Italy. In an ongoing Phase 1/2 clinical trial, ARO-RAGE, Arrowhead’s investigational RNAi therapeutic for the treatment of inflammatory lung diseases, achieved mean target ge

CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced that it has executed financing transactions resulting in approximately $200 million of proceeds to the Company through a financing including an exchange into equity of current debt and a new convertible debt instrument from Nant Capital, LLC, an entity affiliated with Dr. Patrick Soon-Shiong, the Company’s Founder, Executive Chairman and Global Chief Scientific and Med

SEATTLE & IRVINE, Calif.--(BUSINESS WIRE)--Visus Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing multi-targeted ophthalmic therapies for indications in the front and back of the eye, today announced that Ben Bergo, co-founder and chief executive officer, will present at the Baird 2023 Global Healthcare Conference on September 12th, 2023, at the InterContinental New York Barclay hotel. The presentation is scheduled for 8:30 AM Eastern Time on Tuesday, Septembe

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that it will host an in-person Investor Day on Thursday, September 14, 2023, beginning at 8:00 a.m. Eastern Time in New York City. The “Vision 2026” Investor Day will highlight key company initiatives and projects including, several next generation product pipeline initiatives, as well as the significant global growth oppo

IRVINE, Calif.--(BUSINESS WIRE)--A new prospective, multicenter study, recently published in The Lancet Neurology has revealed the significant prognostic value of the Neurological Pupil index™ (NPi®), measured using the NeurOptics NPi Pupillometer, in evaluating disease progression and predicting outcomes for patients with acute brain injury. This international study, coordinated by the Milano Bicocca University, enrolled 514 patients diagnosed with traumatic brain injury (TBI), aneurysmal suba

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the Wells Fargo Healthcare Conference on Friday, September 8, 2023 at 9:30 a.m. Eastern time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the webcast will be available following the live presentation. About Masimo Masimo (Nasdaq: MASI) is a global technology company that develops and produces a wide array of industry-leading

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus hosted its first University+ PBPK Summer Camp, an intensive 8-week PBPK modeling course for more than 80 attendees from 26 countries.

IRVINE, Calif.--(BUSINESS WIRE)-- #DETOURSystem--Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, announces that the U. S. Centers for Medicare & Medicaid Services (CMS) granted a New Technology Add-on Payment (NTAP) for the DETOUR System, an FDA-designated Breakthrough Device, as part of its Fiscal Year 2024 Hospital Inpatient Prospective Payment System. NTAP was created to facilitate patient ac

LOS ANGELES--(BUSINESS WIRE)-- #calderamedical--Caldera Medical Acquires Atlantic Therapeutics to Expand Portfolio in Women’s Health

IRVINE, Calif.--(BUSINESS WIRE)--Today Viseon Inc. announces the first US clinical use of the First-of-its-Kind 4K Hawkeye™ device for Anterior Lumber Interbody Fusion (ALIF). The Viseon Hawkeye 4K System represents a significant line extension of an enabling, towerless, state-of-the-art advanced digital visualization system involving no capital equipment expense and occupying no operating room footprint. ALIF procedures are routinely done across most spine surgery practices and represents a si

LOS ANGELES--(BUSINESS WIRE)--The Celiac Disease Foundation, a trusted partner in optimizing patient recruitment and retention, today announces the launch of its iRecruitCeliac platform, which brings together solutions to accelerate enrollment in clinical trials for celiac disease and comorbid conditions. With an established, 30-year track record of patient engagement, the Foundation understands that patient recruitment and retention pose significant challenges in bringing new drugs to market.

SANTA MONICA, Calif. & EMERYVILLE, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS), the direct-to-consumer healthcare apparel and lifestyle brand, and Eko Health, Inc. (“Eko”), a leading innovator in digital health technology for heart and lung disease detection, today announced the launch of the FIGS | Eko CORE 500™ Digital Stethoscope. The collaboration unites two companies that have reinvented two healthcare professionals’ mainstays — scrubs and stethoscopes — through new technology, modern

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced it is hosting the second Women in Endodontics summit. Taking place in Tucson, Ariz. at the Miraval Resort from Sept. 14-16, the event aims to support leadership and both personal and professional growth through education and peer connection. Now in its second year, Women in Endodontics brings together world-renowned speakers and industry

IRVINE, Calif.--(BUSINESS WIRE)-- #appointments--CG Oncology Announces Key Executive Appointments in Commercialization, Medical and Manufacturing Operations

THOUSAND OAKS, Calif.--(BUSINESS WIRE)---- $ATRA #CART--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today reported the grant of 3,250 restricted stock units of Atara’s common stock to one newly hired employee. This award was approved by the Compensation Committee of Atara’s Board of Directors and granted under the Atara

PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events: Citi’s 18th Annual BioPharma Conference – September 6, 2023 Type: 1-on-1 Investor Meetings European Respiratory Society (ERS) International Congress – September 9-13, 2023 Date: Sept. 10, 2023, 12:30-14:00 CEST Type: Poster Session 146 Title: A Clinical-Stage Inhaled RNAi Therapeutic for Pulmonary Inflammation Mediates Durable RA

LOS ANGELES--(BUSINESS WIRE)--Alan Auerbach, CEO of Puma Biotechnology, will present a corporate update at the H.C. Wainwright Global Investment Conference beginning on 9/11/23.

THOUSAND OAKS, Calif.--(BUSINESS WIRE)---- $ATRA #CART--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal Touchon, President and Chief Executive Officer, will participate in a Cell Therapies in Autoimmune panel discussion at the Citi 18th Annual BioPharma Conference on Thursday, September 7, 2023 at

POMONA, Calif.--(BUSINESS WIRE)--PSC Software®, a global leader in innovative software solutions, is excited to announce the launch of its redesigned website. This substantial update reflects the company's commitment to staying at the forefront of technology and offering its users an immersive and user-friendly online experience. PSC’s Software solutions, such as ACE Enterprise, ACE Essentials, and ACE Inspection, have been used by clients worldwide, since 2009. These software solutions have ac

IRVINE, Calif.--(BUSINESS WIRE)--The 10-hospital Franciscan Missionaries of Our Lady Health System is adopting multiple Masimo technologies.

IRVINE, Calif.--(BUSINESS WIRE)-- #ClinicalTrials--Immunis, Inc., a private biotech creating novel cellular secretome therapies for age and disease-related immune decline, was bestowed Corporate LiveWire’s prestigious “Innovation and Excellence Award.” Corporate LiveWire is highly regarded in the business world, acknowledging the stellar performance of leading companies with technological innovation. Immunis' cutting-edge research and transformative secretome technologies have undoubtedly set the company apart a

SAN FRANCISCO & LOS ANGELES & SAN DIEGO--(BUSINESS WIRE)--Biocom California, the association representing the life science industry of California, issued the following statement regarding the official release of the first ten drugs subject to price controls under the Inflation Reduction Act. The statement can be attributed to Joe Panetta, Biocom California’s president and CEO: “Today the Biden Administration released the first ten drugs that will be subject to price controls to coincide with th

IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, is scheduled to participate in the following investor conferences in September: Event: Wells Fargo Healthcare Conference Date: Friday, September 8 Presentation time: 10:15 a.m. Eastern Time Event: Morgan Stanley Healthcare Conference Date: Monday, September 11 Presentation time: 10:00 a.m. Eas

LOS ANGELES--(BUSINESS WIRE)---- $CDXC #NAD--ChromaDex Corp. (NASDAQ:CDXC), a global authority on Nicotinamide Adenine Dinucleotide (NAD+) research and healthy aging, shares findings from a preclinical study, as reported in the peer-reviewed journal International Journal of Molecular Sciences by a team of scientists led by Dr. Yue Yang, Assistant Professor of Research in Pharmacology at Weill Cornell Medicine in New York. This preclinical study utilized stable isotopes, the gold standard method in research, t

LANCASTER, Calif.--(BUSINESS WIRE)--Dr. Viera Lukacova, Chief Science Officer of Simulations Plus, was selected to be a Fellow of the American Association of Pharmaceutical Scientists.

HAWTHORNE, Calif.--(BUSINESS WIRE)--OSI Systems, Inc. (the “Company” or “OSI Systems”) (NASDAQ: OSIS) today announced its financial results for the fourth quarter and fiscal year ended June 30, 2023. Deepak Chopra, OSI Systems’ Chairman and Chief Executive Officer, stated, “Our fourth quarter performance was stellar as revenues grew by 22% and non-GAAP adjusted earnings per share increased 36% year over year. Fourth quarter bookings were outstanding, leading to record backlog as we concluded a

IRVINE, Calif.--(BUSINESS WIRE)-- #ALTO--Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, is pleased to announce that Lucas Buchanan has been appointed to the Endologix Board of Directors. Lucas Buchanan is currently the Chief Financial Officer and Chief Operating Officer at Silk Road Medical, Inc. He is widely recognized for his contributions to Silk Road Medical as the company introduced a

IRVINE, Calif.--(BUSINESS WIRE)-- #4k--Integrated Endoscopy, a medical device company pioneering the development of cordless 4K, low-cost, single-use endoscopes for the arthroscopic surgery market, today announced the availability of two new versions of its flagship product, the NUVIS (pronounced “nu-vee”) Single-Use Arthroscope, making the technology accessible to surgeons using a variety of arthroscopic surgical platforms. This news makes NUVIS the only 4k cordless arthroscope that is universally c

IRVINE, Calif.--(BUSINESS WIRE)--The Masimo Stork™ smart home baby monitoring system is now available in the U.S. for purchase online and on shelves at major and specialty retailers.

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that its management is scheduled to participate in the Wells Fargo Healthcare Conference on Wednesday, September 6, 2023, at 12:45 p.m. ET in Boston, MA. A live and archived webcast for this event will be available in the Investors section of the Glauko

IRVINE, Calif.--(BUSINESS WIRE)-- #CEMark--Telesair, Inc., an innovator of next generation respiratory technology, announced today that it has received CE (Conformité Européenne) Marking under the European Medical Device Regulation for its Bonhawa High Flow Oxygen Therapy (HFOT) system for use in the treatment of patients with respiratory insufficiency. The Bonhawa HFOT is one of the first respiratory therapeutic devices from a US based company to receive CE Mark under the new European Medical Device Reg

IRVINE, Calif.--(BUSINESS WIRE)-- #ClinicalTrials--Immunis, Inc., a private biotech company developing novel cellular secretome therapies for age and disease-related immune decline, is delighted that its Chairman, Dr. Hans Keirstead, will present at the Advanced Therapies Conference in Portugal. The Advanced Therapies Conference is a premier gathering of thought leaders and pioneers from around the globe, engaging in discourse on the latest innovations in therapeutic research. Dr. Keirstead will share insights f

LOS ANGELES--(BUSINESS WIRE)--Digital Transformation Opportunities Corp. (Nasdaq: DTOCU) (the “Company” or “DTOC”) today announced that, on August 21, 2023, it has received notice from Digital Transformation Sponsor LLC (the “Sponsor”) of its intention to further extend the period of time by which the Company must complete its initial business combination with American Oncology Network, LLC (“AON”) from August 31, 2023 to September 30, 2023. The Company also announced that, on August 21, 2023,